tradingkey.logo
搜索

TherapeuticsMD Inc

TXMD
添加自选
2.160USD
-0.050-2.26%
收盘 07/01, 16:00美东报价延迟15分钟
25.00M总市值
138.82市盈率 TTM

TherapeuticsMD Inc

2.160
-0.050-2.26%
查看详细走势图
TradingKey 图表
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-2.26%

5天

+8.00%

1月

+0.93%

6月

+32.52%

今年开始到现在

+32.52%

1年

+86.21%

关键数据
2.210今开
2.320最高
36.09K成交量
138.82市盈率 TTM
--市盈率动
--股息TTM
0.31%换手率
2.210昨收
2.155最低
65.51K成交额
亏损市盈率静
0.93市净率
0.00%股息率 TTM
0.23%ROA
2.95052周最高
0.92量比
-2.18M净利润
11.57M总股本
0.0156每股收益TTM
0.60Beta
0.32%ROE
0.98152周最低
7.47%振幅
100.00%毛利率
25.00M总市值
1.71回报/风险
4.87%风险率

TradingKey TherapeuticsMD Inc股票评分

单位: USD 更新时间: 2026-06-30

操作建议

TherapeuticsMD Inc当前公司基本面数据相对健康,增长潜力很大。当前估值合理,在药品行业排名113/157位。机构持股占比非常高,中期看,股价处于上升通道。近一个月,市场表现较强,技术面和基本面综合得分较高,较强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。

TherapeuticsMD Inc评分

相关信息

行业排名
113 / 157
全市场排名
356 / 4569
所属行业
药品

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
看空

TherapeuticsMD Inc亮点

亮点风险
TherapeuticsMD, Inc. is a pharmaceutical royalty company, which primarily collects royalties from its licensees. It receives royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. It granted a license to commercialize IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands and assigned its exclusive license to commercialize ANNOVERA to Mayne Pharma. IMVEXXY (estradiol vaginal inserts) pharmaceutical product is for the treatment of moderate-to-severe dyspareunia. BIJUVA pharmaceutical product is a Food and Drug Administration (FDA)-approved bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. ANNOVERA pharmaceutical product is a one-year ring-shaped contraceptive vaginal system (CVS).
业绩高增长
公司营业收入稳步增长,连续3年增长132.10%
业绩增长期
公司处于发展阶段,最新年度总收入3.02M美元
估值高估
公司最新PE估值142.03,处于3年历史高位
机构加仓
最新机构持股3.82M股,环比增加9.99%
詹姆斯·西蒙斯持仓
明星投资者詹姆斯·西蒙斯持仓,最新持仓市值0.00
活跃度增加
近期活跃度增加,过去20天平均换手率-0.51

分析师目标

根据 0 位分析师
--
评级
--
目标均价
--
涨幅空间

TherapeuticsMD Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

TherapeuticsMD Inc简介

TherapeuticsMD, Inc. is a pharmaceutical royalty company, which primarily collects royalties from its licensees. It receives royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. It granted a license to commercialize IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands and assigned its exclusive license to commercialize ANNOVERA to Mayne Pharma. IMVEXXY (estradiol vaginal inserts) pharmaceutical product is for the treatment of moderate-to-severe dyspareunia. BIJUVA pharmaceutical product is a Food and Drug Administration (FDA)-approved bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. ANNOVERA pharmaceutical product is a one-year ring-shaped contraceptive vaginal system (CVS).
公司代码TXMD
公司TherapeuticsMD Inc
CEOWalker (Marlan D)
网址https://www.therapeuticsmd.com/

常见问题

TherapeuticsMD Inc(TXMD)的当前股价是多少?

TherapeuticsMD Inc(TXMD)的当前股价是 2.21。

TherapeuticsMD Inc的股票代码是什么?

TherapeuticsMD Inc的股票代码是TXMD。

TherapeuticsMD Inc股票的52周最高点是多少?

TherapeuticsMD Inc股票的52周最高点是2.95。

TherapeuticsMD Inc股票的52周最低点是多少?

TherapeuticsMD Inc股票的52周最低点是0.98。

TherapeuticsMD Inc的市值是多少?

TherapeuticsMD Inc的市值是25.93M。

TherapeuticsMD Inc(TXMD)股票的每股收益(EPS TTM)是多少

TherapeuticsMD Inc(TXMD)股票的每股收益(EPS TTM)是-0.05。